Table 2.
Unique Patient Characteristics During Implementation Phase (2020) and Comparison Period (2019)a
| Characteristics | Comparison Periodb | Implementation Phasec | P |
|---|---|---|---|
| (N = 3169) | (N = 1501) | ||
| Age, y | <.001d | ||
| < 45 | 1287 (41) | 732 (49) | |
| 45–65 | 1025 (32) | 486 (32) | |
| > 65 | 857 (27) | 283 (19) | |
| Men | 1118 (35) | 532 (35) | .51 |
| English speaking | 2981 (94) | 1475 (98) | <.001d |
| Race/ethnicity | .002d | ||
| Non-Hispanic White | 1639 (52) | 826 (55) | |
| Black/African American | 190 (6) | 91 (6) | |
| Asian | 666 (21) | 240 (16) | |
| Hispanic/Latino | 298 (9) | 152 (10) | |
| Unknown | 376 (12) | 192 (13) | |
| Comorbidity burden | <.001d | ||
| No comorbid conditions | 2260 (71) | 1153 (77) | |
| 1-2 comorbid conditions | 558 (18) | 205 (14) | |
| ≥ 3 comorbid conditions | 351 (11) | 143 (10) | |
| Referral diagnosis category | <.001d | ||
| Orthopedic | 2485 (78) | 1131 (75) | |
| Neurologic | 298 (9) | 119 (8) | |
| Pelvic health | 227 (7) | 158 (11) | |
| General/unspecified | 159 (5) | 93 (6) | |
| Insurance type | <.001d | ||
| Commercial | 2060 (65) | 1091 (73) | |
| Medicaid | 357 (11) | 136 (9) | |
| Medicare | 725 (23) | 255 (17) | |
| Other | 27 (1) | 19 (1) |
a Data presented as n (%).
b Comparison period: March 22, 2019, to May 16, 2019.
c Implementation phase: March 22, 2020, to May 16, 2020.
d Significant Fisher exact test (P < .05).